title: Adjuvant therapy for early colon cancer: current status.
abstract: Adjuvant chemotherapy after resection of the primary tumour reduces the risk of death by an absolute 5% in UICC (Union Internationale Contre le Cancer) stage II colon cancer and about 15-20% in stage III. Adjuvant treatment has to be evaluated separately for each stage due to the different clinical situations: in stage II about 80% of patients are cured by surgery alone, whereas only about half of patients with stage III are cured by surgery. Decisions on adjuvant treatment need to be discussed with the patient on an individual basis, and take into account patient characteristics (performance status, age, co-morbidity and patient preference) as well as cancer features (pathological stage, grading and overall risk of relapse). Recently, capecitabine in combination with oxaliplatin has been approved for treatment of stage III colon cancer, providing the benefits of an oral fluoropyrimidine. Predictive markers for guidance of treatment have gained importance, particularly in stage II disease. Microsatellite instability, a well known prognostic factor, might be predictive for a lack of activity of fluorouracil treatment in some stage II patients. Furthermore, patients aged ≥70 years do not seem to obtain the same benefit from combination therapy compared with those aged <70 years. The impact of these current developments on daily clinical practice is discussed in this review.
authors.affiliation: University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. a.stein@uke.de
authors.forename: Alexander
authors.initials: A
authors.lastname: Stein
authors.forename: Sonja
authors.initials: S
authors.lastname: Hiemer
authors.forename: Hans-Joachim
authors.initials: HJ
authors.lastname: Schmoll
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects / Q000379:methods*; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D006801:Humans
chemical_list: D000970:Antineoplastic Agents
references.citation: N Engl J Med. 2001 Oct 11;345(15):1091-7
references.pmid: 11596588
references.citation: J Clin Oncol. 2007 Apr 20;25(12):1539-44
references.pmid: 17442997
references.citation: Oncology. 2000;58(1):52-9
references.pmid: 10644941
references.citation: J Natl Cancer Inst. 2004 Aug 4;96(15):1128-32
references.pmid: 15292384
references.citation: J Clin Oncol. 2009 Feb 20;27(6):872-7
references.pmid: 19124803
references.citation: Ann Surg. 2002 Apr;235(4):458-63
references.pmid: 11923600
references.citation: Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):498-507
references.pmid: 17255271
references.citation: Cancer Res. 1998 Nov 15;58(22):5248-57
references.pmid: 9823339
references.citation: J Clin Oncol. 1995 Dec;13(12):2936-43
references.pmid: 8523058
references.citation: Cancer Res. 2003 Sep 15;63(18):5738-44
references.pmid: 14522894
references.citation: J Clin Oncol. 2005 May 20;23(15):3526-35
references.pmid: 15908663
references.citation: Dtsch Arztebl Int. 2009 Dec;106(51-52):843-8
references.pmid: 20062582
references.citation: Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005390
references.pmid: 18646127
references.citation: J Clin Oncol. 2005 Jan 20;23(3):609-18
references.pmid: 15659508
references.citation: Eur J Cancer. 2010 Mar;46(4):765-81
references.pmid: 20116997
references.citation: J Clin Oncol. 2010 Jul 10;28(20):3219-26
references.pmid: 20498393
references.citation: Curr Oncol. 2011 Jan;18(1):18-25
references.pmid: 21331278
references.citation: N Engl J Med. 2008 Oct 23;359(17):1757-65
references.pmid: 18946061
references.citation: Br J Cancer. 2001 Nov 16;85(10):1437-43
references.pmid: 11720425
references.citation: N Engl J Med. 2004 Jun 3;350(23):2335-42
references.pmid: 15175435
references.citation: J Clin Oncol. 2011 Jan 1;29(1):17-24
references.pmid: 21098318
references.citation: N Engl J Med. 2005 Jun 30;352(26):2696-704
references.pmid: 15987918
references.citation: J Natl Cancer Inst. 1988 Mar 2;80(1):30-6
references.pmid: 3276901
references.citation: J Clin Oncol. 2009 Jul 1;27(19):3117-25
references.pmid: 19451425
references.citation: N Engl J Med. 2007 Nov 15;357(20):2040-8
references.pmid: 18003960
references.citation: J Clin Oncol. 2009 Jul 10;27(20):3385-90
references.pmid: 19414665
references.citation: J Clin Oncol. 2001 Mar 15;19(6):1787-94
references.pmid: 11251010
references.citation: J Clin Oncol. 1990 Sep;8(9):1466-75
references.pmid: 2202789
references.citation: J Clin Oncol. 2007 Mar 1;25(7):767-72
references.pmid: 17228023
references.citation: N Engl J Med. 2001 Apr 19;344(16):1196-206
references.pmid: 11309634
references.citation: J Clin Oncol. 1999 Nov;17(11):3553-9
references.pmid: 10550154
references.citation: J Clin Oncol. 2006 May 20;24(15):2359-67
references.pmid: 16710035
references.citation: Gastroenterology. 2004 Feb;126(2):394-401
references.pmid: 14762775
references.citation: JAMA. 1976 Jun 28;235(26):2825-8
references.pmid: 946987
references.citation: J Clin Oncol. 2003 Aug 1;21(15):2912-9
references.pmid: 12885809
references.citation: Ann Oncol. 2010 Jun;21(6):1323-1360
references.pmid: 19948741
references.citation: Lancet. 1995 Apr 15;345(8955):939-44
references.pmid: 7715291
references.citation: J Clin Oncol. 1989 Oct;7(10):1447-56
references.pmid: 2778478
references.citation: Cancer. 2006 Dec 1;107(11):2581-8
references.pmid: 17078055
references.citation: Lancet. 2011 Jun 18;377(9783):2103-14
references.pmid: 21641636
references.citation: Int J Cancer. 2010 Dec 15;127(12):2893-917
references.pmid: 21351269
references.citation: Lancet. 2000 May 6;355(9215):1588-96
references.pmid: 10821362
references.citation: J Clin Oncol. 2009 Apr 10;27(11):1814-21
references.pmid: 19273709
references.citation: J Clin Oncol. 2005 Dec 1;23(34):8671-8
references.pmid: 16314627
references.citation: J Clin Oncol. 2007 Jun 1;25(16):2198-204
references.pmid: 17470851
references.citation: J Clin Oncol. 2003 Aug 1;21(15):2896-903
references.pmid: 12885807
references.citation: Lancet. 2007 Dec 15;370(9604):2020-9
references.pmid: 18083404
references.citation: N Engl J Med. 2004 Jun 3;350(23):2343-51
references.pmid: 15175436
references.citation: J Clin Oncol. 2007 Jan 1;25(1):102-9
references.pmid: 17194911
references.citation: J Clin Oncol. 2011 Jan 1;29(1):11-6
references.pmid: 20940184
references.citation: J Clin Oncol. 2006 Oct 10;24(29):4685-91
references.pmid: 16966692
references.citation: Acta Oncol. 2005;44(8):904-12
references.pmid: 16332600
references.citation: N Engl J Med. 1990 Feb 8;322(6):352-8
references.pmid: 2300087
references.citation: N Engl J Med. 2009 Apr 2;360(14):1408-17
references.pmid: 19339720
references.citation: N Engl J Med. 2003 Jul 17;349(3):247-57
references.pmid: 12867608
references.citation: Ann Oncol. 2010 May;21 Suppl 5:v78-81
references.pmid: 20555108
references.citation: J Natl Cancer Inst. 2011 Jun 8;103(11):863-75
references.pmid: 21597022
references.citation: J Clin Oncol. 2009 Jul 1;27(19):3109-16
references.pmid: 19451431
references.citation: J Clin Oncol. 2010 Jan 20;28(3):466-74
references.pmid: 20008640
references.citation: J Clin Oncol. 2005 Jun 1;23(16):3706-12
references.pmid: 15867200
references.citation: J Clin Oncol. 2007 Aug 20;25(24):3732-8
references.pmid: 17704423
references.citation: J Natl Cancer Inst. 2007 Mar 21;99(6):433-41
references.pmid: 17374833
references.citation: J Clin Oncol. 1999 May;17(5):1356-63
references.pmid: 10334519
references.citation: Ann Oncol. 2005 Apr;16(4):549-57
references.pmid: 15695501
references.citation: J Clin Oncol. 2010 Jan 20;28(3):460-5
references.pmid: 20008641
references.citation: Ann Oncol. 2009 Apr;20(4):674-80
references.pmid: 19179549
references.citation: N Engl J Med. 2000 Jan 13;342(2):69-77
references.pmid: 10631274
references.citation: J Clin Oncol. 1999 May;17(5):1349-55
references.pmid: 10334518
references.citation: Ann Oncol. 2010 May;21 Suppl 5:v70-7
references.pmid: 20555107
references.citation: Eur J Cancer. 2009 Feb;45(3):365-73
references.pmid: 18722765
references.citation: J Clin Oncol. 2006 Sep 1;24(25):4085-91
references.pmid: 16943526
references.citation: J Clin Oncol. 2004 May 15;22(10):1797-806
references.pmid: 15067028
references.citation: Ann Oncol. 2008 Feb;19(2):400-2
references.pmid: 18245135
references.citation: J Natl Cancer Inst. 2004 Oct 6;96(19):1420-5
references.pmid: 15467030
references.citation: J Clin Oncol. 2006 May 1;24(13):2059-64
references.pmid: 16648506
references.citation: Gastroenterology. 1994 Apr;106(4):899-906
references.pmid: 8143995
references.citation: N Engl J Med. 2004 Jul 22;351(4):337-45
references.pmid: 15269313
references.citation: J Clin Oncol. 2011 Apr 1;29(10):1261-70
references.pmid: 21383284
references.citation: J Clin Oncol. 1998 Jan;16(1):295-300
references.pmid: 9440756
references.citation: J Clin Oncol. 2010 Jan 10;28(2):264-71
references.pmid: 19949014
references.citation: J Clin Oncol. 2007 Aug 10;25(23):3456-61
references.pmid: 17687149
references.citation: J Clin Oncol. 2005 Dec 1;23(34):8664-70
references.pmid: 16260700
references.citation: J Clin Oncol. 2011 Apr 10;29(11):1465-71
references.pmid: 21383294
references.citation: Dis Colon Rectum. 2008 May;51(5):503-7
references.pmid: 18322753